Cargando…
Considerations for use of direct oral anticoagulants in arterial disease
Cardiovascular diseases including coronary heart disease, stroke, and peripheral arterial disease were responsible for an estimated 18 million deaths in 2017. Despite advances in management over the past several decades, these patients continue to have substantial risk of subsequent cardiovascular e...
Autores principales: | Siegal, Deborah M., Anand, Sonia S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162231/ https://www.ncbi.nlm.nih.gov/pubmed/34095731 http://dx.doi.org/10.1002/rth2.12502 |
Ejemplares similares
-
Reproductive issues in women on direct oral anticoagulants
por: Beyer‐Westendorf, Jan, et al.
Publicado: (2021) -
Direct oral anticoagulants for unusual‐site venous thromboembolism
por: Riva, Nicoletta, et al.
Publicado: (2021) -
The contact activation system and vascular factors as alternative targets for Alzheimer's disease therapy
por: Singh, Pradeep K., et al.
Publicado: (2021) -
Visualizing thrombosis to improve thrombus resolution
por: Weisel, John W., et al.
Publicado: (2021) -
GPIbα is the driving force of hepatic thrombopoietin generation
por: Karakas, Danielle, et al.
Publicado: (2021)